Influence of human milk oligosaccharides on adherence of bifidobacteria and clostridia to cell lines by Musilova, Sarka et al.
INFLUENCE OF HUMAN MILK
OLIGOSACCHARIDES ON ADHERENCE
OF BIFIDOBACTERIA AND CLOSTRIDIA
TO CELL LINES
SARKAMUSILOVA*, NIKOLMODRACKOVA, IVO DOSKOCIL, ROMAN SVEJSTIL and
VOJTECH RADA
Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and
Natural Resources, Czech University of Life Sciences Prague, Prague, Czech Republic
(Received: 17 December 2016; accepted: 17 May 2017)
Adhesion of gut bacteria to the intestinal epithelium is the ﬁrst step in their
colonization of the neonatal immature gut. Bacterial colonization of the infant gut is
inﬂuenced by several factors, of which the most important are the mode of delivery
and breast-feeding. Breast-fed infants ingest several grams of human milk oligosac-
charides (HMOs) per day, which can become receptor decoys for intestinal bacteria.
The most abundant intestinal bacteria in vaginally delivered infants are biﬁdobacteria,
whereas infants born by cesarean section are colonized by clostridia. The inﬂuence of
HMOs on the adhesion of ﬁve strains of intestinal bacteria (three biﬁdobacterial strains
and two clostridial strains) to mucus-secreting and non-mucus-secreting human
epithelial cells was investigated. Biﬁdobacterium biﬁdum 1 and Biﬁdobacterium
longum displayed almost the same level of adhesion in the presence and absence
of HMOs. By contrast, adhesion of Clostridium butyricum 1 and 2 decreased from
14.41% to 6.72% and from 41.54% to 30.91%, respectively, in the presence of HMOs.
The results of this study indicate that HMOs affect bacterial adhesion and are an
important factor inﬂuencing bacterial colonization of the gut. Adhesion of the tested
bacteria correlates with their ability to autoaggregate.
Keywords: human milk oligosaccharides, biﬁdobacteria, clostridia, cell lines,
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Introduction
Bacterial colonization of the infant gut is inﬂuenced by several factors, of
which the most important are the mode of delivery and breast-feeding. Breast milk
is a complex source of nutrients for infants and has protective effects against
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diseases while their immune system matures [1–3]. This defensive function is
attributed to antimicrobial peptides and proteins and human milk oligosaccharides
(HMOs). Infants ingest several grams of HMOs daily and these are the ﬁrst
prebiotics they are exposed to [4]. These carbohydrates guide the development of
the neonatal gut and shape the intestinal microbiota toward a health-promoting
community of biﬁdobacteria, which are the predominant gut bacteria of vaginally
delivered and breast-fed infants [5]. However, the predominant bacteria in infants
delivered by cesarean section are clostridia, which can be gradually replaced by
biﬁdobacteria during the breast-feeding period [6]. HMOs assist implantation of
biﬁdobacteria into the intestines of infants. Microbial adhesion is the ﬁrst step in
colonization of the neonatal intestinal tract. It has been explored whether auto-
aggregation of bacteria increases their ability to adhere. Del Re et al. [7]
investigated the relationship between autoaggregation and the adhesion ability
of Biﬁdobacterium longum. The aim of this study was to evaluate the inﬂuence of
HMOs on the adhesion of biﬁdobacteria and clostridia to mucus-secreting HT29-
MTX and non-mucus-secreting Caco-2 cell lines. We hypothesized that biﬁdo-
bacteria would adhere better than clostridia in the presence of HMOs and that their
ability to adhere would correlate with their autoaggregation properties.
Materials and Methods
Bacterial strains
Biﬁdobacterium longum subsp. infantis was isolated from the probiotic
product Inﬂoran (Laboratory Pharmaceutical S.I.T., S.r.l., Italy). Biﬁdobacterium
biﬁdum 1 and 2 were isolated from fecal samples of 3-month-old vaginally
delivered breast-fed infants. Biﬁdobacteria were isolated using selective TPY agar
(Scharlau, Spain) modiﬁed by the addition of mupirocin (100 mg/L) and acetic
acid (1 mL/L) according to the method described by Rada and Petr [8] and
identiﬁed by subspecies-speciﬁc polymerase chain reaction [9, 10]. Clostridium
butyricum 1 and 2 were isolated from fecal samples of 2-month-old breast-fed
infants born by cesarean section using reinforced clostridial medium agar
(Oxoid, UK) according to Vlková et al. [10]. Fresh fecal samples of infants were
aseptically transferred to tubes containing Wilkins–Chalgren broth (Oxoid),
transported to the laboratory, and analyzed within 2 h. The samples were serially
diluted in the Wilkins–Chalgren broth under anaerobic conditions and analyzed
using selective media. All strains were identiﬁed by ﬂuorescence in situ hybrid-
ization kits with speciﬁc probes (C. butyricum group and Biﬁdobacterium spp.;
Ribo Technologies, the Netherlands). They were further characterized by the API
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50 CHL biochemical test (bioMérieux, Marcy l’Etoile, France) and their auto-
aggregation properties were determined according to Vlková et al. [10].
Aggregation assay
Bacteria were cultivated in Wilkins–Chalgren broth at 37 °C for 24 h. The
tubes were shaken and absorbance at 600 nm (A600) was measured in the upper
part of the suspension at 0, 0.5, 1, 2, 3, 4, and 5 h [10]. Aggregation ability (Agg)
was expressed as the Agg percentage after 5 h of incubation, which was calculated
using the following formula: Agg %= [1− (A600 of upper suspension at time
t/A600 of total bacterial suspension at time 0)] × 100 at different time points [7].
Cell culture
The human colorectal adenocarcinoma cell line Caco-2 and the mucus-
secreting cell line HT29-MTX-E12 were obtained from Sigma-Aldrich (Prague,
Czech Republic). The cell lines were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 20% fetal bovine serum, 1% non-essential
amino acids, 100 μg/mL penicillin, and 100 μg/mL streptomycin. Cultures were
incubated at 37 °C in a humidiﬁed atmosphere of 5% (v/v) CO2 and 95% air. The
medium was changed every 2 days, and the cells were subcultured at 80%
conﬂuency every week. All solutions were purchased from Sigma-Aldrich.
HMOs preparation
HMOs were isolated and puriﬁed from breast milk samples obtained from
volunteer mothers as described by Rockova et al. [11]. Stock solution of HMOs
(c= 23.5 g/L) were prepared using phosphate-buffered saline (PBS) and syringe
microﬁlters (pore size 0.2 μm; Whatman® Anotop® IC and LC; Whatman GmbH,
Germany) and used immediately after preparation.
Adhesion assays
The adhesion assay was performed using a previously described method
[12] with slight modiﬁcations. Caco-2 and HT29-MTX cells were seeded in
NUNC 24-well culture plates at a density of 3.6 × 104 and 0.4 × 104 cells per well,
respectively, and grown for 14± 1 days until conﬂuent at 37 °C in a humidiﬁed
atmosphere of 5% (v/v) CO2 and 95% air. The culture medium was changed
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every 2 days. Before adding the bacterial suspension, the cell monolayers were
washed with PBS to remove antibiotics. Thereafter, 900 μL of HMO solution
was added to the washed cell monolayers, whereas 900 μL of DMEM (without
supplements) was added to the control wells. The ﬁnal concentration (c= 21.5 g/L)
of HMOs was the same as in the human colostrum. Subsequently, 100 μL of
the bacterial suspension was added. For each strain, controls and treated wells were
prepared in triplicate. Then, the plates were incubated at 37 °C for 1 h in an
atmosphere of 5% CO2. After incubation, the cell layers were gently washed three
times with PBS to remove non-adherent bacteria. Finally, the cell layers were lysed
by the addition of 300 μL of 1% Triton X-100 (Sigma-Aldrich) per well for 1 min,
followed by the addition of 700 μL of PBS. The lysed suspension of cells with viable
adhered bacteria was diluted to a bacterial concentration of 1× 107 cfu/mL.
The bacterial counts of the collected samples were determined using the
plate method after serial dilution on cultivation media (Wilkins–Chalgren anaer-
obe agar, Oxoid). All plates were anaerobically incubated at 37 °C for 48 h and
then bacteria were counted.
Adhesion of bacteria was evaluated according to the following formula:
Adhesion= ðbacterial count of sample=bacterial count of controlÞ × 100
where the control represents 100% adhesion.
Statistical analyses
Differences in adherence and autoaggregation of bacteria were evaluated by
performing multiple range comparisons using Duncan’s multiple range test [this
procedure was used as a precaution against the known type I error inﬂation
problem that arises when many (necessarily interdependent) comparisons are
tested]. Signiﬁcance was set at P≤ 0.05. All statistical analyses were performed
using STATGRAPHICS Centurion XVII (Manugistics, Rockville, MD, USA).
Results
Autoaggregation of bacteria was examined on the basis of their sedimenta-
tion characteristics (Table I). The tested strains either autoaggregated (Agg+) or
did not autoaggregate (Agg−) according to the phenotypes described by Del Re
et al. [7]. B. biﬁdum 1 autoaggregated, had a high Agg percentage of nearly 50%
(49.90%) after 4 h and formed a precipitate, resulting in a clear solution, which
correlated with its ability to adhere to cell lines in the presence of HMOs.
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C. butyricum 1 demonstrated weak aggregation (Agg+, 11.90%). The other tested
strains (two biﬁdobacterial strains and one clostridial strain) were unable to
aggregate (Agg−, ≤10%) and constant turbidity was observed in the tubes. The
adhesion of all ﬁve strains to human Caco-2/HT29-MTX cells was examined. The
ability of B. biﬁdum 1 and B. longum to adhere did not differ signiﬁcantly between
medium containing HMOs and medium lacking of HMOs (Figure 1). B. biﬁdum 1
and B. longum displayed almost the same level of adhesion in the presence
of HMOs (32.59%± 4.81% and 37.59%± 4.97%, respectively) and the absence
of HMOs (38.91%± 6.83% and 39.43%± 5.47%, respectively) (Figure 1).
B. biﬁdum 2 was not able to autoaggregate (8.55± 1.18) and its ability to adhere
Table I. Autoaggregation (Agg %) of the tested strains (measured after 5 h)
Strain Agg %
Biﬁdobacterium biﬁdum 1 49.90± 1.33
Biﬁdobacterium biﬁdum 2 8.55± 1.18
Biﬁdobacterium longum subsp. infantis 1.51± 0.09
Clostridium butyricum 1 11.90± 1.64
Clostridium butyricum 2 5.70± 0.34
Note: Values are means of triplicates± standard deviations.
Figure 1.Ability of the tested strains to adhere to cell lines with HMOs and without HMOs. *Values
are signiﬁcantly different (P< 0.05)
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to cell lines was similar as to B. biﬁdum 1 without HMOs and lower with HMOs.
By contrast, C. butyricum 1 and 2 and B. biﬁdum 2 adhered better in medium
lacking of HMOs than in medium containing HMOs.
Discussion
The Agg test is often used for preliminary screening to identify potentially
adherent bacteria [13]. One of the tested strains (B. biﬁdum 1) had a high Agg and
was able to adhere equally well in the presence and absence of HMOs. On the
other hand, B. longum did not aggregate and its adhesion ability was similar in the
presence and absence of HMOs, as in the case of B. biﬁdum 1. Bacterial adhesion
to the intestinal mucosa is important for colonization of the infant gut. The
bacterial adhesion to intestinal mucosa is one of the most important properties for
colonization of the infant gut. It belongs to many health beneﬁts of probiotic
bacteria [14]. Oligosaccharides can inﬂuence the adhesion of bacteria. Inconsistent
results have been reported between tested oligosaccharides and bacterial strains. In
general, oligosaccharides have antiadhesive effects on gut bacteria. Chitooligo-
saccharides inhibit the adhesion of pathogenic Escherichia coli [15].
Kadlec and Jakubec [16] also tested several prebiotic oligosaccharides
and reported that fructooligosaccharides and galactooligosaccharides generally
decrease adhesion of the tested probiotic strains (Lactobacillus, Lactococcus,
Enterococcus, and Biﬁdobacterium spp.). It is well known that biﬁdobacteria are
also able to utilize different carbon source such are rafﬁnose-series oligosacchar-
ides present in soya beans and other legumes oligosaccharides [17]. Altamimi
et al. [18] ﬁrst investigated the antiadhesive effect of oligosaccharides on mixed
bacteria imitating the gut microbiota in vitro. They reported that clostridial strains
are the most strongly inﬂuenced bacteria in mixed cultures. In this study,
clostridial strains were most inﬂuenced by HMOs.
In addition to their prebiotic effect, HMOs also have inhibitory effects on
adhesion of pathogens, such as Campylobacter jejuni, enteropathogenic E. coli,
Salmonella enterica serovar Fyris, and Pseudomonas aeruginosa to the intestinal
human cell line Caco-2 [19]. Some HMOs act as molecular decoys by inhibiting
the potential pathogens.
Therefore, we tested the inﬂuence of HMOs on common bacteria of the
infant gut microbiota. Adhesion of some biﬁdobacterial strains was not inﬂuenced
by prebiotic HMOs, while other bacteria were less able to adhere in the presence of
HMOs. The ability of four of the ﬁve tested strains to adhere to epithelial cells
correlated with their ability to autoaggregate, similar to the ﬁndings of a previous
study [7].
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Conclusions
HMOs may act as antiadhesive molecules and therefore prevent adhesion
not only of potential pathogens but also of potential probiotic microorganisms.
The ability to adhere to the epithelial surface of the gut seems to be strain-speciﬁc.
The impact of HMOs is also strain-speciﬁc, but bacteria that can autoaggregate
probably adhere better. Aggregation is an advantage, but not a requirement, for
bacterial adhesion to the mucus layer.
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